Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
44.05
-2.80 (-5.98%)
May 5, 2025, 4:00 PM EDT - Market closed
Guardant Health Analyst Ratings
Total Analysts
21
Consensus Rating
Strong Buy
Price Target
$52.33
Upside
+18.80%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Buy Maintains $52 → $57 | Buy | Maintains | $52 → $57 | +29.40% | May 5, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $60 → $65 | Strong Buy | Maintains | $60 → $65 | +47.56% | May 1, 2025 |
| Stifel | Stifel | Strong Buy Maintains $53 → $60 | Strong Buy | Maintains | $53 → $60 | +36.21% | May 1, 2025 |
| Barclays | Barclays | Buy Maintains $55 → $60 | Buy | Maintains | $55 → $60 | +36.21% | May 1, 2025 |
| TD Securities | TD Securities | Strong Buy Maintains $56 → $60 | Strong Buy | Maintains | $56 → $60 | +36.21% | May 1, 2025 |
| UBS | UBS | Strong Buy Maintains $65 → $70 | Strong Buy | Maintains | $65 → $70 | +58.91% | May 1, 2025 |
| Barclays | Barclays | Buy Maintains $60 → $55 | Buy | Maintains | $60 → $55 | +24.86% | Apr 10, 2025 |
| Mizuho | Mizuho | Buy Initiates $55 | Buy | Initiates | $55 | +24.86% | Apr 10, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $55 | Buy | Reiterates | $55 | +24.86% | Mar 26, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $42 → $52 | Buy | Maintains | $42 → $52 | +18.05% | Mar 6, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $34 → $50 | Buy | Maintains | $34 → $50 | +13.51% | Feb 26, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $56 | Strong Buy | Reiterates | $56 | +27.13% | Feb 24, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $47 → $52 | Buy | Maintains | $47 → $52 | +18.05% | Feb 24, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $42 → $60 | Strong Buy | Maintains | $42 → $60 | +36.21% | Feb 24, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $49 → $56 | Strong Buy | Maintains | $49 → $56 | +27.13% | Feb 21, 2025 |
| Raymond James | Raymond James | Buy Reiterates $39 → $59 | Buy | Reiterates | $39 → $59 | +33.94% | Feb 21, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.